Literature DB >> 9114429

Determination of drug susceptibility of Mycobacterium tuberculosis through mycolic acid analysis.

E Garza-González1, M Guerrero-Olazarán, R Tijerina-Menchaca, J M Viader-Salvadó.   

Abstract

In the present work a rapid method to determine the susceptibility of Mycobacterium tuberculosis to isoniazid and streptomycin by determining levels of mycolic acids by high-performance liquid chromatography (HPLC) was developed. Mycobacterial growth kinetics in the presence and absence of antituberculosis drugs was characterized by evaluating the total area corresponding to mycolic acid peaks (TAMA). Results show a linear relationship between the logarithm of CFU per milliliter and TAMA and show that it is possible to detect growth inhibition of M. tuberculosis in the presence of isoniazid or streptomycin by using HPLC in 3 and 4 days, respectively.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9114429      PMCID： PMC232751          DOI： 10.1128/jcm.35.5.1287-1289.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  10 in total

1.  Identification of mycobacteria by high-performance liquid chromatography.

Authors:  W R Butler; K C Jost; J O Kilburn
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

2.  Separation of Mycobacterium bovis BCG from Mycobacterium tuberculosis and Mycobacterium bovis by using high-performance liquid chromatography of mycolic acids.

Authors:  M M Floyd; V A Silcox; W D Jones; W R Butler; J O Kilburn
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

3.  High-performance liquid chromatography patterns of mycolic acids as criteria for identification of Mycobacterium chelonae, Mycobacterium fortuitum, and Mycobacterium smegmatis.

Authors:  W R Butler; J O Kilburn
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

4.  Routine application of high-performance liquid chromatography for identification of mycobacteria.

Authors:  L Thibert; S Lapierre
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

5.  Identification of Mycobacterium avium complex strains and some similar species by high-performance liquid chromatography.

Authors:  W R Butler; L Thibert; J O Kilburn
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

6.  Curvilinear-gradient high-performance liquid chromatography for identification of mycobacteria.

Authors:  L S Guthertz; S D Lim; Y Jang; P S Duffey
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

7.  Identification of Mycobacterium tuberculosis and M. avium complex directly from smear-positive sputum specimens and BACTEC 12B cultures by high-performance liquid chromatography with fluorescence detection and computer-driven pattern recognition models.

Authors:  K C Jost; D F Dunbar; S S Barth; V L Headley; L B Elliott
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

8.  An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms.

Authors:  C L Daley; P M Small; G F Schecter; G K Schoolnik; R A McAdam; W R Jacobs; P C Hopewell
Journal:  N Engl J Med       Date:  1992-01-23       Impact factor: 91.245

9.  High-performance liquid chromatography of mycolic acids as a tool in the identification of Corynebacterium, Nocardia, Rhodococcus, and Mycobacterium species.

Authors:  W R Butler; D G Ahearn; J O Kilburn
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

10.  Identification of major slowly growing pathogenic mycobacteria and Mycobacterium gordonae by high-performance liquid chromatography of their mycolic acids.

Authors:  W R Butler; J O Kilburn
Journal:  J Clin Microbiol       Date:  1988-01       Impact factor: 5.948
  10 in total
  8 in total

Review 1.  Treatment and prevention of multidrug-resistant tuberculosis.

Authors:  I Bastian; R Colebunders
Journal:  Drugs       Date:  1999-10       Impact factor: 9.546

2.  Mycolic acid index susceptibility method for Mycobacterium tuberculosis.

Authors:  J M Viader-Salvadó; E Garza-González; R Valdez-Leal; M A del Bosque-Moncayo; R Tijerina-Menchaca; M Guerrero-Olazarán
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

Review 3.  Mycolic acid analysis by high-performance liquid chromatography for identification of Mycobacterium species.

Authors:  W R Butler; L S Guthertz
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

4.  Flow cytometric testing of susceptibilities of Mycobacterium tuberculosis isolates to ethambutol, isoniazid, and rifampin in 24 hours.

Authors:  S M Kirk; R F Schell; A V Moore; S M Callister; G H Mazurek
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

5.  Rapid, standardized method for determination of Mycobacterium tuberculosis drug susceptibility by use of mycolic acid analysis.

Authors:  Nicole Parrish; Gerard Osterhout; Kim Dionne; Amy Sweeney; Nicole Kwiatkowski; Karen Carroll; Kenneth C Jost; James Dick
Journal:  J Clin Microbiol       Date:  2007-10-03       Impact factor: 5.948

Review 6.  Tuberculosis in the developing world: recent advances in diagnosis with special consideration of extensively drug-resistant tuberculosis.

Authors:  Louis Grandjean; David A J Moore
Journal:  Curr Opin Infect Dis       Date:  2008-10       Impact factor: 4.915

7.  The Assessment of Viability of M. Tuberculosis after Exposure to CPC Using Different Methods.

Authors:  Gomathi Sekar; R Lakshmi; N Selvakumar
Journal:  Int J Bacteriol       Date:  2014-01-28

8.  Antimycobacterial susceptibility testing methods for natural products research.

Authors:  Juan Gabriel Bueno Sánchez; Vladimir V Kouznetsov
Journal:  Braz J Microbiol       Date:  2010-06-01       Impact factor: 2.476
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.